For the possible significance see Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes, 2024
| "Vibrio sputorum" Prevot 1940| ATCC 33562| ATCC 35980| Campylobacter sputorum| Campylobacter sputorum (Prevot 1940) Veron and Chatelain 1973 (Approved Lists 1980) emend. On et al. 1998| Campylobacter sputorum (Prevot 1940) Veron and Chatelain 1973 (Aproved Lists 1980) emend. Roop et al. 1986| CCUG 9728| CIP 103749| LMG 7795| LMG:7795| NCTC 11528| strain Forsyth ER33| Vibrio sputorum| VPI S-17
Gastrointestinal Infections: Campylobacter concisus is known to cause gastroenteritis in humans, characterized by symptoms such as diarrhea (which can be watery or bloody), abdominal pain, fever, nausea, and vomiting. The severity and duration of symptoms can vary, ranging from mild and self-limiting to more severe and prolonged cases requiring medical attention.
Inflammatory Bowel Disease (IBD): There is growing evidence to suggest that Campylobacter concisus may be associated with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Some studies have reported higher prevalence rates of Campylobacter concisus in individuals with IBD compared to healthy controls, suggesting a potential role in disease pathogenesis or exacerbation.
Chronic Gastrointestinal Symptoms: Campylobacter concisus has been implicated in cases of chronic or persistent gastrointestinal symptoms, including chronic diarrhea, abdominal pain, and bloating. In some individuals, the bacterium may establish long-term colonization in the gastrointestinal tract, leading to ongoing symptoms.
Transmission: Campylobacter concisus is primarily transmitted through the consumption of contaminated food or water, particularly raw or undercooked poultry, unpasteurized milk, and contaminated produce. Person-to-person transmission and exposure to contaminated environments may also contribute to the spread of infection.
Diagnosis and Treatment: Diagnosis of Campylobacter concisus infection is typically confirmed through stool culture or molecular methods. Treatment may involve supportive care to manage symptoms, including fluid replacement to prevent dehydration. In some cases, antibiotic therapy may be prescribed for severe or prolonged infections, although antimicrobial resistance is a growing concern.
Prevention: Preventive measures to reduce the risk of Campylobacter concisus infection include thorough cooking of poultry and other meats, pasteurization of milk, avoiding consumption of raw or undercooked foods, practicing good hygiene (such as handwashing), and ensuring proper sanitation in food preparation environments.
The above data is from 1000 Healthy Individuals done using Shotgun(10 Millions reads) provide courtesy of Precision Biome.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
![]() |
NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | Average | Median | Minimum | Maximum | Std.Dev. | Skew | 25 - 75 Percentile | 5 - 95 Percentile | Lab Ranges | Box-Plot-Whiskers | Harmonic Mean | Geometric Mean | Obs. |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thorne | 0.1217 | 0.0007 | 0.0002 | 0.0001 | 0.0102 | 0.0021 | 0.7316 | 0.0001 - 0.0003 | 0.0001 - 0.0012 | -0.0034 - 0.0048 | -0.0003 - 0.0007 | 0.0002 | 0.0002 | 23 |
Thryve | 0.0073 | 0.0052 | 0.0048 | 0.0008 | 0.0164 | 0.0052 | 0.2358 | 0.0015 - 0.005 | 0.0009 - 0.0141 | -0.005 - 0.0154 | -0.0038 - 0.0103 | 0.0021 | 0.0033 | 9 |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 0 | 0 | 0 | 0 |
PrecisionBiome | 2.33772170759039E-05 | 2.33772170759039E-05 | 0 | 0 |
|
And display level must be raised above public.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]